BROOKS LABORATORIES LTD. - 533543 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JYOTI SANCHETIDesignation :- Company Secretary and Compliance Officer BROOKS LABORATORIES LTD. - 533543 - Shareholding for the Period Ended June 30, 2021
Brooks Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here BROOKS LABORATORIES LTD. - 533543 - Resubmission Of Audited Financial Results
Resubmission of Audited Financial Results for the quarter and year ended 31.03.2021 with separate declaration of Audit Report with unmodified opinion for Audited Standalone and Consolidated Financial Results Brooks Laboratories Ltd - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of audited financial results for the financial year ended 31st march, 2021. Brooks Laboratories Ltd - 533543 - Closure of Trading Window
Intimation of closure of trading window for the declaration of unaudited financials results for the first quarter ended 30th june 2021 BROOKS LABORATORIES LTD. - 533543 - Audited Financial Results For The Financial Year Ended 31.03.2021
Audited Financial Results for the financial year ended 31.03.2021 BROOKS LABORATORIES LTD. - 533543 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended 31.03.2021 BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Notice of Board Meeting to be held on 30.06.2021 for approval of Audited Financial Results for the financial year ended 31.03.2021 Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for Approval Of Audited Financial Results For The 4Th Quarter And Financial Year Ended 31.03.2021
BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Approval of Audited Financial Results for the 4th quarter and financial year ended 31.03.2021 BROOKS LABORATORIES LTD. - 533543 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayBROOKS LABORATORIES LTD. 2CINL24232HP2002PLC000267 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 1.57 4Highest Credit Rating during the previous FY B 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Jyoti Sancheti Designation: Company Secretary cum Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Prashant Rathi Designation: Chief Financial Officer EmailId: [email protected] Date: 26/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.